Surgery Partners, Inc.SGRYNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank56
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
23.68%
↓ 78% vs avg
Percentile
P56
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
106.84%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 23.68% |
| Q3 2025 | 2.83% |
| Q2 2025 | 1255.00% |
| Q1 2025 | -94.61% |
| Q4 2024 | 70.86% |
| Q3 2024 | -21.26% |
| Q2 2024 | 103.44% |
| Q1 2024 | -34.98% |
| Q4 2023 | -40.15% |
| Q3 2023 | 100.77% |
| Q2 2023 | -30.07% |
| Q1 2023 | 934.72% |
| Q4 2022 | -75.76% |
| Q3 2022 | -29.45% |
| Q2 2022 | -47.24% |
| Q1 2022 | 305.08% |
| Q4 2021 | 32.21% |
| Q3 2021 | 547.83% |
| Q2 2021 | -95.42% |
| Q1 2021 | 464.04% |
| Q4 2020 | -66.91% |
| Q3 2020 | -85.21% |
| Q2 2020 | 522.95% |
| Q1 2020 | 14.96% |
| Q4 2019 | -55.36% |
| Q3 2019 | 113.11% |
| Q2 2019 | 30.24% |
| Q1 2019 | -54.99% |
| Q4 2018 | 54.84% |
| Q3 2018 | -25.69% |
| Q2 2018 | 31.70% |
| Q1 2018 | -44.80% |
| Q4 2017 | 443.11% |
| Q3 2017 | -53.59% |
| Q2 2017 | -38.05% |
| Q1 2017 | 7.70% |
| Q4 2016 | 71.97% |
| Q3 2016 | -61.42% |
| Q2 2016 | 93.29% |
| Q1 2016 | 4.36% |